A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Clinical trial NCT05804669 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05804669
Sponsor: Crinetics Pharmaceuticals Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cushing Syndrome Cushing Disease Ectopic ACTH Syndrome

Start date: 2023-10-12
Primary completion: 2026-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.